The purpose of this task order is to procure influenza a/astrakhan/3212/2020

Ended Awarded Last action

Contract number
75A50122F61004
Awardee
Awarding agency
Obligated
$30,739,088

Award facts

Contract value 100% obligated
$30,739,088.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Holly Springs, NC, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00005 $0
Other Administrative Action P00004 · The purpose of this task order is for the acquisition of influenza a/astrakhan/3212/2020 (H5N8) virus vaccine candidate and clinical trial. $0
Supplemental Agreement for work within scope P00003 · The purpose of this modification is to amend the statement of work, clin 0006 to include additional activities under the purview of the base IDIQ clin 0006.… $0
Other Administrative Action P00002 · The purpose of this modification is to transfer bulk lot and final container materials from task order 75A50122F61004 to task order 75A50123F61005 for storage… $0
Funding Only Action P00001 · The purpose of this modification is to CO-formulate the antigen and adjuvant of the remaining batch that is scheduled to expire on march 06, 2023 $609,150
Original award $30,129,938

About this award

Written by GovTribe AI ·

The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a delivery order valued at $30.7 million to Seqirus Inc. on September 19, 2022, with completion expected by September 18, 2025. This task order, issued under IDIQ Contract #75A50122D00004, procures Influenza A/Astrakhan/3212/2020 (H5N8)-like master and working seed lots along with a vaccine candidate and clinical trial support. The contract utilizes a firm fixed-price structure with no set-aside designation and is performed at Seqirus's state-of-the-art manufacturing facility in Holly Springs, North Carolina.

Seqirus Inc., a division of CSL Seqirus, is a leading developer and manufacturer of pandemic preparedness vaccines and medical countermeasures for the federal government. This delivery order falls under Seqirus's broader $13.4 billion IDC with HHS ASPR, which encompasses multiple task orders totaling over $116 million for vaccine production, antigen procurement, clinical research, and strategic stockpile maintenance. The H5N8 vaccine candidate procurement supports the federal government's pandemic preparedness objectives by advancing medical countermeasures against potential avian influenza threats and maintaining the nation's capacity to respond rapidly to emerging infectious disease scenarios.

Quick answers

Who was awarded contract 75A50122F61004?

75A50122F61004 was awarded to Seqirus Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 19, 2022.

How much is contract 75A50122F61004 worth?

The government has obligated $30,739,088 on 75A50122F61004.

Is contract 75A50122F61004 an order under another contract?

Yes. 75A50122F61004 is a delivery order under 75A50122D00004, an indefinite delivery contract.

Was contract 75A50122F61004 competed?

The extent of competition for 75A50122F61004 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login